Julie Russo • February 5, 2024
Volunteer!

Share Your Story (SYS)

Happy Heart Month!  February is going to be a busy month for the HCMA but, with the help of our volunteers, it truly makes the load a lot lighter!

To learn more about HCMA volunteer opportunities and get involved, contact julie@4hcm.org or click HERE.

HCMA Theme of the Month Stories

The HCMA themes for the month of February is “HCM Awareness” and “Sharing Stories of Life with HCM” featuring the story of Lisa Salberg, HCMA Founder and CEO.

“I was 12 years old, and standing in the school nurse’s office waiting to get my heart listened to.  The doctor, a little old man, sat on a round stool looking bored. As the stethoscope rose to my chest – suddenly he looked interested, maybe even a little panicked, he called over the nurse to take a listen.  I had a pretty good idea of what was happening, and it was frightening but, kids were watching and I had to stay cool…”

To read more about Lisa’s HCM journey, click HERE.

Heart Month HCM Heroes of the Day : During February 2024 (American Heart Month), we will be featuring one HCM Hero patient story each day while using social media to ensure their story reaches a broader audience. Many thanks to our Share Your Story volunteers who worked with us to present the story of their HCM journey during the month of February to help spread awareness about HCM.

If you are a patient (or the parent/guardian of a patient) and are interested in sharing your story about your HCM journey, we need patient stories now more than ever to help educate and spread awareness about HCM.  We especially need stories to support our legislative efforts to pass the HCM Act into law and to pass a proclamation/resolution designating HCM Awareness Day on the 4 th Tuesday of February every year in every state. To sign up to Share Your Story, click the following link:  https://bit.ly/3DNBKJI   Under “Projects” choose “Share My Story Volunteer Group”.

HCMA Ambassador Program 

HCMA Featured Ambassador for February 2024 – Susan Shapiro

A little about Susan:  After losing another family member to HCM, Susan used what she had learned from the HCMA as she set out to educate her family members about risk assessment, genetic testing, and COEs in hopes of preventing another tragedy… Click HERE to learn more about Susan and follow her, and our other HCMA Ambassador volunteers, on social media. 

#4hcm

#BigHeartBigLife 

#hypertrophiccardiomyopathy 

If you would like to share your HCM experience via social media as an HCMA Ambassador, click here to apply for future workshops. 

Legislative Advocacy

We are ready for “The Hill” with m any thanks to those who volunteered to join us as we embark on our first visit to the Capitol to begin working with Members of Congress to address the needs of the HCM community. 

On Wednesday, February 14th (Valentine’s Day!), our volunteers will be meeting us in Washington, DC at 7 AM (you KNOW what they say about the “early bird”!).  We will assign teams of 3 to 4 to work together attending pre-scheduled meetings with Members of Congress, and/or their staff.  Our goal is to share patient stories and drive home the message of the importance of finding the undiagnosed, the need to adequately fund research, and the importance of breaking down the barriers to proper treatment. In between meetings, we will be handing out Valentine’s Day candies and printed invitations to members of targeted committees, inviting them to attend an HCMA-hosted legislative briefing & luncheon on February 15th. 

On Thursday, February 15th, we will start the day at 7:30 AM with more meetings with Members of Congress and/or their staff until 12 Noon where we will convene at the Rayburn House in Washington, DC for an HCMA-hosted Bipartisan Congressional Lunch Briefing. This briefing brings patients, parents, clinicians, and thought leaders together to discuss issues of great importance to our community with Members of Congress:

• Why screening for these heart disorders must become the norm – especially among underserved populations and those entering Medicare.

• Why access to proper treatment can save lives and reduce healthcare costs.

• Why research must be adequately funded.

• Why policymakers should support the development and approval of safe and effective therapies- and access

Free Online Patient Discussion Groups

Our online discussion group meetings are recurring, but you must register for each meeting date. Our meeting dates, times, and topics are updated regularly, so check our event calendar regularly to join a meeting (or more than one) best suited for you!  

HCMA’s February 2024 Featured Discussion Group Leader:  Gwen Mayes

Gwen hosts a free online “Emotional Support” discussion group monthly. Click on our event calendar for exact dates and times to register for Gwen’s, or any of our other volunteer led online discussion group.   Our free online discussion groups are open to all.

About Gwen:   “As a discussion group leader, I focus on self-awareness and stress management.  During my career, I was a physician assistant, lawyer, and spent 30 years as a health policy leader in Washington, DC…” Click HERE to learn more about Gwen and to view other online discussion group leader bios and themes.                

HCMA Blog

By Erica Friedman June 26, 2025
Investigative journalists Debbie Cenziper, Megan Rose, Brandon Roberts and Irena Hwang from Pro Publica and NPR have concluded a 14-month long investigation into the quality of generic drugs coming into the United States from overseas. Among the many voices that spoke up for American patients was HCMA Founder and CEO, Lisa Salberg who has felt the effects of low-quality drugs personally. Salberg believes that fixing this problem is something we can do, even in this time, when even health care is highly politicized. Read the key takeaways from ProPublica’s 14-month investigation into the FDA’s oversight of foreign drugmakers in Threat in Your Medicine Cabinet: The FDA’s Gamble on America’s Drugs .
A light blue and dark blue paintbrush stroke intersect to make a stylized
By Erica Friedman June 18, 2025
Alnylam press release on the European Commission approval of AMVUTTRA® (vutrisiran) forwild-type or hereditary transthyretin amyloidosis in adult patients with cardiomyopathy (ATTR-CM) as an additional indication
Light & dark blue brush stroke that intersect create an abstract letter 'a' next to the word Alnylam
By Erica Friedman June 17, 2025
AMVUTTRA® (vutrisiran) has been approved by the U.S. Food and Drug Administration (FDA) to treat ATTR-CM in adults.
More Posts